{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-019153","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2025-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.254897+00:00","generated_at":"2026-05-26T00:40:44.516772+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"medium","headline":"Applied DNA Sciences special meeting fails quorum; warrant approval delayed","bullets":["Reconvened special meeting on Feb 28, 2025, had only 16,413,535 shares present, short of one-third outstanding requirement.","No action taken on proposal to approve exercise of Series C & D warrants from October 2024 offering.","Company is obligated to call another stockholder meeting to seek warrant stockholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-019153","json":"https://secwatch.observer/filing/0001104659-25-019153.json","markdown":"https://secwatch.observer/filing/0001104659-25-019153.md","text":"https://secwatch.observer/filing/0001104659-25-019153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465925019153/0001104659-25-019153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465925019153/tm257916d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T00:40:44.516772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}